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ABSTRACT                        In order to create an animal model of human inhalational exposure by industrial 
metal fumes, nanoparticulate metal oxides (MnO2, CdO2, PbO) were synthesized and instilled 
into the trachea of rats 5 times a week for 6 weeks (metal doses per kg b.w.: 2.63 and 5.26 mg 
Mn; 0.04 and 0.4 mg Cd; 2 and 4 mg Pb). At the end, the rats’ body weight gain during the treat-
ment was determined, the animals had an open field session to investigate their spontaneous 
motility, and finally spontaneous and stimulus-evoked cortical activity was recorded in urethane 
anaesthesia. Mn caused decrease of open field ambulation and rearing, Cd had no effect, 
whereas Pb caused decreased rearing and increased ambulation. Spontaneous cortical activity 
was shifted to higher frequencies with each metal. Cortical evoked potentials had lengthened 
latency, mainly with Mn and Cd; and increased frequency dependence with Cd and Pb but hardly 
with Mn. The effects proved indirectly that the metal content of the nanoparticles had access 
from the airways to the CNS. Our method seems suitable for modelling human nervous system 










Figure 1. Weight gain of the control and treated rats during the 6 
weeks treatment period. The data (mean + SD, n=10) represent the 
difference in the rats’ body weight measured on week 0 and week 6. 
The metals and treatment groups are indicated on the abscissa and in 
the insert, respectively (see Table 1 for explanation). **, ***: p<0.01, 
0.001 vs. Con; ##: p<0.01 vs. W.
Group Code Substance
Dose
(mg metal / 
kg b.w.)
Untreated control Con -- --
Vehicle control W Distilled water --
Manganese low dose LD-Mn
MnO2 nanosuspension
2.63
Manganese high dose HD-Mn 5.26
Cadmium low dose LD-Cd
CdO2 nanosuspension
0.04
Cadmium high dose HD-Cd 0.4
Lead low dose LD-Pb
PbO nanosuspension
2
Lead high dose HD-Pb 4
Table 1. Treatment groups and doses of the metal oxide nano-
particles.
Figure 2. Open field activity after 6 weeks treatment with Mn, Cd 
and Pb containing nanoparticles (top, middle and bottom panel, 
respectively). The data (mean + SD, n=10) represent the time spent 
with the activity forms given on the abscissa. For control and treated 
groups, see insert in the top panel. *, **: p<0.05, 0.01 vs. Con; #, ##: 
p<0.05, 0.01 vs. W.
Figure 3. Band spectrum of the electrocorticogram recorded from the 
somatosensory cortex of the rats after 6 weeks treatment with Mn, Cd 
and Pb (top, middle and bottom panel, respectively). Abscissa: groups. 
Ordinate: relative power of the ECoG bands (for the bar filling pattern 
of the bands, see insert in the top panel). *, **: p<0.05, 0.01 vs. Con; 
#, ##: p<0.05, 0.01 vs. W, always between identical bands.
Discussion
Figure 4. Latency of the somatosensory evoked potentials obtained 
with stimulation frequency of 1, 2 and 10 Hz (see insert in the top panel) 
in Mn, Cd and Pb treated rats. Ordinate: treatment groups. Mean + 
SD, n=10. *, **, ***: p<0.05, 0.01, 0.001 vs. Con; #, ##: p<0.05, 0.01 vs. 
W; °: p<0.05 vs. 1 Hz stimulation within the same group.
Figure 5. Latency of the visual and auditory evoked potentials (see 
insert in the top panel) in Mn, Cd and Pb treated rats. Ordinate: treat-
ment groups. Mean + SD, n=10. *, **, ***: p<0.05, 0.01, 0.001 vs. Con; 
#, ##: p<0.05, 0.01 vs. W.
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